
Lachlan J. Smith
· Ph.D.University of Pennsylvania · Otolaryngology
Active 1982–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Lachlan James Smith, Ph.D., is a Professor of Orthopaedic Surgery at the Perelman School of Medicine at the University of Pennsylvania, affiliated with the McKay Orthopaedic Research Laboratory. His research focuses on the pathophysiology and treatment of degenerative and developmental disorders affecting the spine and synovial joints. His work encompasses basic mechanistic studies, translational studies in animal models, and clinical studies in human patients, utilizing advanced techniques in molecular biology, biochemistry, and bioengineering. Dr. Smith's research bridges tissue engineering, biomaterials, drug delivery, and stem cell fields, aiming to arrest disease progression, restore spine and joint function, and promote long-term tissue regeneration. He employs novel large and small animal models to study disease etiology and evaluate therapeutics, working within a multidisciplinary team of biologists, bioengineers, clinicians, and veterinarians.
Research topics
- Medicine
- Biomedical engineering
- Materials science
- Biology
- Anatomy
Selected publications
Journal of Orthopaedic Research® · 2020-02-24 · 46 citations
articleOpen accessSenior authorCorrespondingIntervertebral disc degeneration is implicated as a leading cause of low back pain. Persistent, local inflammation within the disc nucleus pulposus (NP) and annulus fibrosus (AF) is an important mediator of disc degeneration and negatively impacts the performance of therapeutic stem cells. There is a lack of validated large animal models of disc degeneration that recapitulate clinically relevant local inflammation. We recently described a goat model of disc degeneration in which increasing doses…
Combined Hydrogel and Mesenchymal Stem Cell Therapy for Moderate-Severity Disc Degeneration in Goats
Tissue Engineering Part A · 2020-06-17 · 45 citations
articleOpen accessSenior authorCorrespondingIntervertebral disc degeneration is a cascade of cellular, structural, and biomechanical changes that is strongly implicated as a cause of low-back pain. Current treatment strategies have poor long-term efficacy as they seek only to alleviate symptoms without preserving or restoring native tissue structure and function. The objective of this study was to evaluate the efficacy of a combined triple interpenetrating network hydrogel (comprising dextran, chitosan, and teleostean) and mesenchymal ste…
The FASEB Journal · 2023-12-12 · 8 citations
articleOpen accessSenior authorCorrespondingIntervertebral disc degeneration is a leading cause of chronic low back pain. Cell-based strategies that seek to treat disc degeneration by regenerating the central nucleus pulposus (NP) hold significant promise, but key challenges remain. One of these is the inability of therapeutic cells to effectively mimic the performance of native NP cells, which are unique amongst skeletal cell types in that they arise from the embryonic notochord. In this study, we use single cell RNA sequencing to demons…
JOR Spine · 2025-05-27 · 4 citations
articleOpen accessCorrespondingIntroduction: Intervertebral disc degeneration is strongly implicated as a cause of low back pain. Although the precise pathophysiological mechanisms remain elusive, perturbations in nutrition that adversely impact the cellular microenvironment of the central nucleus pulposus (NP) may be contributing factors. A comprehensive understanding of this microenvironment, including changes in nutrient availability as a function of degeneration, is critical for the development of effective cell-based tre…
bioRxiv (Cold Spring Harbor Laboratory) · 2023-05-22 · 4 citations
preprintOpen accessSenior authorCorrespondingIntervertebral disc degeneration is a leading cause of chronic low back pain. Cell-based strategies that seek to treat disc degeneration by regenerating the central nucleus pulposus hold significant promise, but key challenges remain. One of these is the inability of therapeutic cells to effectively mimic the performance of native nucleus pulposus cells, which are unique amongst skeletal cell types in that they arise from the embryonic notochord. In this study we use single cell RNA sequencing t…
Recent grants
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration
NIH · $391k · 2021–2024
Bioactive Injectable Implants for Functional Intervertebral Disc Regeneration
NIH · 2026–2029
Mechanisms of Vertebral Bone Disease in Mucopolysaccharidosis VII
NIH · $240k · 2014–2018
Frequent coauthors
- 180 shared
Beth S. Slomine
Kennedy Krieger Institute
- 144 shared
Frank W. Moler
University of Michigan–Ann Arbor
- 144 shared
James R. Christensen
Johns Hopkins University
- 144 shared
Richard Holubkov
University of Utah
- 108 shared
J. Michael Dean
University of Utah
- 108 shared
Faye S. Silverstein
University of Michigan–Ann Arbor
- 95 shared
Robert L. Mauck
Philadelphia VA Medical Center
- 72 shared
M. Nyc
Children's Hospital of Philadelphia
Education
- 2008
Ph.D., Pathology
University of Adelaide
- 2001
B.E., Mechatronic Engineering
University of Adelaide
Similar researchers at University of Pennsylvania
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Lachlan J. Smith
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
